News
Illumina Wins Patent Infringement Suit against BGI in the UK
Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI
AMN Healthcare Ranked by Customers as a Leader in Total Workforce Solutions
AMN Healthcare’s commitment to developing comprehensive and integrated solutions to the challenges faced by healthcare organizations has resulted in a top-ten ranking among leaders in total
Dexcom Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 11, 2021 at 4:30 p.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, February 11, 2020. Management will hold a
AMN Healthcare to Host Fourth Quarter and Full Year 2020 Earnings Conference Call on Thursday, February 18, 2021
AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its fourth quarter and full
Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development
Agilent Technologies Inc.(NYSE: A) is pleased to announce Allison Ballmer has been named the company’s new senior vice president of Strategy and Corporate Development, reporting to Agilent
Humana Healthy Horizons and The Humana Foundation Commit More Than $2.5 Million to COVID-19 Relief in Texas
Humana Healthy Horizons, the Medicaid business of Humana Inc. (NYSE: HUM), and Humana’s philanthropic arm, The Humana Foundation, have announced a more than $2.5 million commitment to COVID-19
Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that its Cognigen division has awarded a
PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing
PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration
Veeva wird die erste Aktiengesellschaft, die in eine gemeinnützige Gesellschaft umgewandelt wird
Veeva Systems (NYSE: VEEV) gab bekannt, dass 99 % der stimmberechtigten Aktionäre mit überwältigender Mehrheit den Vorschlag des Unternehmens unterstützen, eine gemeinnützige Gesellschaft (PBC) zu
Veeva Becomes First Public Company to Convert to a Public Benefit Corporation
Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the
CORRECTING and REPLACING Veeva Becomes First Public Company to Convert to a Public Benefit Corporation
Please replace the release with the following corrected version due to multiple revisions.
The updated release reads:
VEEVA BECOMES FIRST PUBLIC COMPANY TO CONVERT TO A PUBLIC BENEFIT
Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.
Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and
Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it
Simulations Plus to Present at 23rd Annual Needham Virtual Growth Conference
Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief
AMN Healthcare Announces Preliminary Fourth Quarter 2020 Revenue; To Present at J.P. Morgan Healthcare Conference
In connection with the Company’s participation at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, AMN Healthcare Services Inc. (NYSE: AMN) is providing preliminary unaudited
Simulations Plus Reports Record First Quarter FY2021 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today reported
Illumina Announces New and Expanded Oncology Partnerships with Bristol Myers Squibb, Kura Oncology, Myriad Genetics, and Merck to Advance Comprehensive Genomic Profiling
With genetic sequencing at the forefront of precision medicine, Illumina (NASDAQ: ILMN) is pleased to announce a portfolio of new and expanded oncology partnerships that further the company’s
New Bioinformatics Solution Powers Multi-Omics Discovery at Massive Scale
Illumina, Inc. (NASDAQ: ILMN) is transforming genomic data bottlenecks into catalysts with the launch of Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides
Waters APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130
Waters Corporation (NYSE:WAT) today announced that its Xevo TQ-XS atmospheric pressure gas chromatography (APGC) mass spectrometry (MS) platform is an accepted alternative for the identification
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2020 and Provides Initial 2021 Outlook
DexCom, Inc. (Nasdaq: DXCM), the leader in continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2020 to
PerkinElmer Updates Fourth Quarter Outlook; To Hold Earnings Call on Tuesday, February 2, 2021
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates reported and organic revenue growth of approximately 66% and 63%
STAAR Surgical Announces Preliminary Fourth Quarter and Full Year 2020 Results
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided preliminary results for the
NanoString Provides Preliminary Financial and Operational Highlights for Fourth Quarter and FY 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for
Humana Partners with Leading Ohio Nonprofits to Address Food Insecurity and Housing
Health and well-being company Humana Inc. (NYSE: HUM) today announced partnerships with several of Ohio’s leading community service organizations to address social factors that can significantly
Premier, Inc. to Report Fiscal 2021 Second-Quarter Results and Host Conference Call on February 2, 2021
Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 second quarter on Tuesday, February 2, 2021, at approximately 6:30 a.m. ET. The company will